Pharmaceutically acceptable salts of substituted tetrahydrofuran derivatives, crystalline forms thereof and uses thereof
By preparing various medicinal salts of compound 1, the problem of its unsatisfactory physicochemical properties was solved, and a more stable and effective analgesic effect was achieved, which is suitable for treating various types of pain such as chronic pain, acute pain, and inflammatory pain.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- SHANDONG SUNCADIA MEDICINE CO LTD
- Filing Date
- 2025-02-21
- Publication Date
- 2026-06-09
AI Technical Summary
Existing Nav1.8 inhibitors have undesirable defects in terms of drug physicochemical and biological properties, which affects their application in clinical treatment.
Pharmaceutically usable salts of compounds of Formula 1 were developed, including hydrochloride, sulfate, phosphate, methanesulfonate, p-toluenesulfonate, maleate, fumarate and tartrate, etc., and polymorphs were prepared by different chemical ratios and solvent systems to optimize their physicochemical properties.
The stability and pharmaceutical properties of the compound were improved, making it more suitable for industrial production and biological activity. It has analgesic effects and is suitable for treating a variety of pain types.
Smart Images

Figure CN120040431B_ABST